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a b s t r a c t
Signalling pathways are well-known abstractions that explain the mechanisms whereby
cells respond to signals. Collections of pathways form networks, and interactions
between pathways in a network, known as cross-talk, enables further complex signalling
behaviours. While there are several formal modelling approaches for signalling pathways,
none make cross-talk explicit; the aim of this paper is to define and categorise cross-talk
in a rigorous way. We define a modular approach to pathway and network modelling,
based on the module construct in the PRISM modelling language, and a set of generic
signalling modules. Five different types of cross-talk are defined according to various
biologically meaningful combinations of variable sharing, synchronisation labels and
reaction renaming. The approach is illustrated with a case-study analysis of cross-talk
between the TGF-β , WNT and MAPK pathways.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Signalling pathways1 are well-known abstractions that explain how cells respond to signals. They comprise biochemical
reactions that transfer information from a receptor to a target such as the nucleus or mitochondria. Several agent-based,
formalmodelling techniques from computer science have been extended and applied to signalling pathways in recent years,
for example, rewrite rules [1], Petri nets [2] and process algebras [3–7]. However, there has been less focus on collections of
pathways that form networks, and very little on the interactions between pathways, known in the life sciences as cross-talk.
Cross-talk accounts formany useful behaviours, for example, producing a variety of responses to a single signal, and reuse of
proteins between pathways. Cross-talk is an essential aspect of network behaviour, yet there are no known formal models
of pathways that make cross-talk explicit. Here we aim to develop a formal framework for pathway and network modelling
that allows one to explain, categorise, and detect cross-talk in a systematic way. Our long term motivation is to develop
predictive models that inform both systems and synthetic biology.
The paper has four parts. First, we develop a modular modelling framework for pathways and networks, based on the
module construct in the PRISM modelling language and multiway synchronisation. We define a set of generic pathway
modules, including basic signalling pathway behaviours such as Receptor, 3-stage Cascade and Gene Expression. A pathway
is a composition of (instances of) the genericmodules; a network is a composition of pathways.We assume continuous-time
Markov chain (CTMC) semantics.
Second, we give our main contribution, which is to define and categorise cross-talk according to the way pathways
are composed to form a network. Specifically, we consider the combinations of variable sharing, synchronisation labels
and reaction renamings that can give rise to biologically meaningful behaviours. We define five types of cross-talk:
substrate availability, signal flow, receptor function, gene expression and intracellular communication, and show that the
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categorisation is well-defined. We can also generate all possible cross-talk from a given network, which provides a rigorous
way of generating hypotheses to explain data. We give illustrative examples of each type of cross-talk from biological
literature. While we cannot prove our categorisation is complete, we have been unable to find a cross-talk that cannot
be categorised.
Third, we apply the approach to a case-study involving three pathways concerning cell growth and differentiation:
the TGF-β , WNT and MAPK pathways. One interesting result is that we are able to resolve an ambiguity in the literature
concerning one complicated form cross-talk between the WNT and TGF-β pathways.
Finally, we discuss briefly how cross-talk can be detected and categorised for a given model, in the absence of a model
description. Such an approachmaybe usefulwhenwehave amodel that has beenderived fromdata, rather than themodular
description, which may be more appropriate in a synthetic setting (i.e. the design of networks and cross-talk).
The paper is organised as follows.
The following section outlines the background to pathway cross-talk, the temporal logics used in analysis, and related
work on pathway and cross-talk modelling.
Sections 3–5 contribute to the first part of the paper. Section 3 describes the reagent-centric approach tomodelling in the
PRISM language. Each reagent in a reaction is mapped to a process, which is represented by a PRISMmodule with reaction-
labelled transitions. Modules are composed usingmultiway synchronisation over sets of labels.We define two extensions to
the language, to allow for variable sharing and synchronisation over labels within amodule. In Section 4we give an example
set of generic modules and then define a pathway as a composition of (instances of) those modules, modulo label renaming
and hiding. In Section 5 we define a network as a composition of two pathways, possibly with variable sharing, renaming
and synchronisation of labels.
Sections 6 and 7 define and categorise cross-talk. In Section 6 we define how the generic modules can be extended
with additional reactions, and then define cross-talk in terms of the synchronisations and variable sharings in a network.
Section 7 gives our categorisation of the five types of cross-talk. Examples of each are drawn from biological literature and
illustrated using two simple pathways;we give a theorem showing that categorisation iswell-defined.We give an algorithm
to enumerate all cross-talks between two pathways and apply it to the example pathways. We discuss (in Section 6) how to
generalise to higher order networks (i.e. three or more pathways), but explain why for practical purposes we have focused
on pairwise composition.
In the next sections we give preliminary results on the complementary problem — how to detect (Section 8) and
characterise (Section 9) cross-talk in the absence of a model description.
The case-study is in Section 10, where we define a richer set of generic modules, and then apply our approach to the
cross-talk between TGF-β , WNT and MAPK pathways, and compare our results with those in the literature.
There follows a discussion in Section 11, and in Section 12 we give our conclusions and directions for future work.
2. Background
In this section we outline the background to pathway cross-talk, temporal logics, and related work on pathway and
cross-talk modelling.
2.1. Signal transduction: networks, pathways and cross-talk
A cell has many types of receptors that detect extra- or intracellular biochemical signals; signal transduction is the
mechanism whereby a cell responds to a detected signal. The result is a signalling network — a collection of pathways that
comprise biochemical reactions that transfer information from a receptor to a target such as the nucleus or mitochondria.
A typical response initiated at the target is a change in gene expression/protein activation levels, resulting in phenotype
changes.
Pathways were first thought to be a linear series of reactions, but more recent results indicate they are non-linear
[8]. Many of the reactions involved in signalling pathways are enzyme catalysed protein activations, often arranged in a
‘‘signalling cascade’’. In such a cascade, the activated protein on one ‘‘level’’ is the enzyme for the activating reaction of the
next ‘‘level’’, as shown in Fig. 1 using standard biochemical graphical notation. The series of reactions forming the pathway
can diverge or interact upstream/downstream in the chain of reactions forming a feedback/feedforward loop. We note that
pathways are a human abstraction, based on laboratory experiments, to explain and structure the coordination of cellular
activity. Although there is awell-known set of pathways in biological literature, there is a lack of rigorous definitions of what
constitutes a single pathway and cross-talk between pathways. This paper focuses on defining cross-talk between signalling
pathways.
The term cross-talk was first applied to electronic circuits to describe a signal in one circuit having an undesired effect
on another circuit [9]. Cross-talk in this setting is a design flaw: the electronic circuit has been specified and built, and
has resulted in an undesired interaction between signals, called ‘‘signal interference’’. Biochemical cross-talk [10] is an
interaction between signals flowing through two or more signalling pathways in a cell, however, this is not necessarily
indicative of signal interference.
We summarise the three fundamental concepts: networks, pathways and cross-talk, as follows.
Pathway: an abstraction that helps life scientists structure the coordination of cellular activity.
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a b
Fig. 1. (a) the notation used throughout this paper for arcs and nodes, (b) an example of a 2-stage signalling cascade in which the activated protein X
catalyses the activation of protein Y .
Cross-talk: the interaction of two or more pathways.
Network: a collection of pathways and cross-talk that govern how the cell responds to incoming signals.
Throughout the paper the following notation is used. A reaction, for example protein X turns into protein Y , is denoted
by a solid line with an arrow. There are two types of modifiers that change the rate of a reaction, catalysis and inhibition.
Catalysis (increase in the rate of a reaction) is denoted by a dashed line with an arrow. Inhibition (decrease in the rate of a
reaction) is denoted by a solid line with a blunt end. Finally, we distinguish between inactive and active proteins rather than
the various mechanisms by which a protein changes state. An active protein is decorated with ∗. This notation is illustrated
in Fig. 1(a).
2.2. Temporal logics
In this section we give a brief overview of two temporal logics: the qualitative logic CTL (Computational Tree Logic) and
the quantitative logic CSL (Continuous Stochastic Logic). The latter is a quantitative extension of the formerwith probabilities
and timing. In both logics we refer to safety properties (‘‘bad’’ properties to be avoided) and liveness properties (‘‘good’’
properties that capture required functionality).
2.2.1. Computational tree logic
An Atomic Proposition (AP) is a formula in propositional logic that can be evaluated to a boolean value for a state in
a Markov chain. An AP may compare combinations of variables in a Markov chain and constant values, using equalities
and inequalities=,<, ≤, etc. The arithmetic operations+,−, ∗ and /may be applied to any combination of variables and
constant values. Looking ahead to the PRISM model of a simple reaction introduced in the next section in Fig. 2, examples
of APs are: (A > 0), (A > B+ C), and (A = 1).
A CTL formula φ is defined as follows:
φ ::= AP | ¬ φ | φ ∧ φ | φ ∨ φ | A X φ | E X φ | A φ U φ | E φ U φ |
A F φ | E F φ | A G φ | E G φ
where¬, ∨ and ∧ denote ‘‘not’’, ‘‘or’’ and ‘‘and’’ respectively.
Path operators:
Universal A all paths from the state
Existential E at least one path from the state
Temporal operators:
Next X φ φ holds in the next state
Until φ1 U φ2 φ1 holds in every state before φ2
Finally F φ φ holds in some future state
Globally G φ φ holds in every state
We also use the non-standard filter constructφ {ψ } as implemented by PRISM. A filter allows a propertyφ to be checked
from a state other than the initial state of the Markov chain, in this case a state that satisfies ψ .
2.2.2. Continuous stochastic logic
In CSL the path operators A and E are replacedwith the probability operator P◃▹x where x is the probability of the formula
and ◃▹ ∈ {>,≥, <,≤}. Hence the operator A is equivalent to P≥1 and E to P>0. The probability of the formula x can be
returned in the PRISM model checker using P=?.
Furthermore, the temporal operators can have a time bound thus for the Finally operator, F≤10 φ, expresses φ must
become true within 10 time units.
2.3. Related work
There are several computationalmodels of specific pathways that include an aspect of cross-talk. For example, in [11–13],
Ordinary Differential Equations (ODEs) are used to model the cross-talk between the MAPK and AKT pathways, the MAPK
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module A
A : [0..N] init N;
[r1] A > 0 -> e1:(A’ = A - 1);
endmodule
module B
B : [0..N] init N;
[r1] B > 0 -> e2:(B’ = B - 1);
endmodule
module C
C : [0..N] init 0;
[r1] C < N -> e3:(C’ = C + 1);
endmodule
system
A || B || C
endsystem
Fig. 2. A reagent-centric model of A+ B r1−→ C in PRISM.
and PKC pathways, and the hyperosmolar and the pheromone MAPK pathways respectively. The analysis depends on the
pathways involved. In [13] the motivation for modelling is to answer how the pathways maintain signal specificity, given
shared common proteins. Two models are proposed, one that contains mutual inhibition between pathways to limit signal
bleed-through and one that contains scaffold proteins. In [12] the goal is to investigate whether cross-talk has an effect
on bistability, namely whether the signal switches from transient to sustained activation as a consequence of varying the
duration of the signal. Cross-talk is expressed implicitly in computational models, i.e. it is part of the system of equations,
with no explicit reference to pathways or interactions between pathways. Therefore, there is no direct way to reason about
cross-talk, especially to detect or classify the cross-talk.
Formal models are also employed. For example, Petri nets are used to model apoptosis decision-making in the Fas-
induced andmitochondrial DNAdamage pathways, and this includes the Bid controlled cross-talk between them [14]. Fisher
et al. [15] contains a discrete, state-basedmodel of themultiplemodes of intercellular cross-talk between the EGFR and LIN-
12/Notch signalling pathways, developed in the language of Reactive Modules. Model checking is used to check the validity
of themodel and to generate new biological insights. But, intercellular cross-talk is consideredwithin amulti-cellularmodel.
This work bears little relation to intracellular cross-talk, indeed, it is considered a misnomer within parts of the life science
community. Our focus is cross-talk in a single-cell model.
In general, it is difficult to draw any generic methods or techniques from these specific models.
We are aware of only one paper, [1], that addresses a more generic concept of pathway and cross-talk. Models in [1]
are defined using the rewrite rules of the κ calculus; the notion of a ‘‘story’’ corresponds to a pathway and an ‘‘influence
map’’ defines how rules can inhibit each other. Superposition of an influence map with a pathway suggests ways in which a
story’s ending can be delayed or prevented (i.e. delay or prevent pathway output), this can be interpreted as detecting cross-
talk. The pathways of [1] are minimal execution paths to a goal, and thus cannot be compared directly with the established
signalling pathways (as defined by biologists and used in biological literature) that we consider. Nonetheless, we note that
superposition (via renaming and synchronisation) is also fundamental to our approach.
We note this paper extends a preliminary study in [16] in several ways, including enhancements to the PRISM language
and a more rigorous treatment of pathways and types of cross-talk.
3. Reagent-centric modelling
Weadopt a reagent-centric approach [17] tomodelling inwhich each of the reagents in a reaction ismapped to a process,
whose variation reflects increase or decrease in amount of the reagent, through production or consumption. We give a brief
outline as follows.
As an example, the reaction r1 given in chemical notation by A+ B r1−→ C refers to three reagents and so it is modelled
by three processes: A, B and C , which are then composed in parallel, synchronising on the event r1. After the event r1, C
is increased and A and B are decreased. The processes can model individuals (molecules) or populations (concentrations of
biochemical species); we assume the latter here, and an underlying semantics of continuous-time Markov chain (CTMC)
with levels [18].
Definition 1 (CTMC). Given a finite set of atomic propositions AP , a continuous-time Markov chain (CTMC) is a triple
C = (S, R, L) where S is a finite set of states, R : S × S → R≥0 a rate matrix, and L : S → 2AP a labelling of states.
For a given state s, there is a race between outgoing transitions from s if there is more than one state s′ such that R(s, s′) > 0.
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The probability that a transition from s to s′ completes within t time units when R(s, s′) > 0 is determined according to the
distribution 1− e−R(s,s′)·t .
In a CTMCwith levels, states are characterised by concentration ranges, discretised uniformly into N levels with step size
h, for each species. Note, the choice of h applies to all species. Though, we can increase or decrease h depending on the degree
of granularity of the model that we require.2
Definition 2 (CTMC with Levels). The states of a CTMC with levels are vectors of levels s = ([A1], [A2], . . . , [An]), where
for i = 1, 2, . . . , n, Ai is a species, and [Ai] is the level of the species Ai. The transitions represent reactions and each
transition causes a change in the level number of one or more species, the variation in the number of levels depending
on the stoichiometry of the reaction. With each reaction we associate characteristic species vectors pre and post of size n
for the set of reactants and the set of products respectively. The reaction can be fired from a state s if s − pre ≥ 0 and
s− pre+ post ≤ (N, . . . ,N). If a transition from s is taken according to this reaction, the new state is s′ = s− pre+ post .
Assuming all species have the same step size h, stoichiometry 1, and mass action kinetics, then the rate associated with a
transition from state u to state v, when the reactants of u are [R1], [R2], . . . , [Rm] is r∗[R1]∗h∗[R2]∗h···∗[Rm]∗hh .
3.1. Reagent-centric modelling in the PRISM modelling language
Reagent-centric modelling is implemented in a straight forward way in a state-based formalism [4] such as the language
of reactive modules [19] for the PRISM model checker [20]. The PRISM language includes modules with local variables
and labelled transitions, multiway synchronisation between modules and process algebraic operators. Each process is
implemented by a module, and modules are composed with multiway synchronisation on reaction names, which are used
to label transitions.
For example, the PRISM model for the reaction r1 above, i.e. A+ B r1−→ C , is in Fig. 2. There are three modules: A, B and
C , and a system description stating that the three modules run concurrently. Each module has the form: a state variable
denoting the species concentration, followed by transitions labelled by the reactions in which the species is a reagent. In
this case, there is a single transition labelled r1. The transition has the form condition→ rate_exp:assignment, meaningwhen
the condition is true, then perform the assignment at the rate given by the rate expression rate_exp. The assignments in the
first two modules decrease the level by 1 and in the third module increase the level by 1. Initially, there are N levels of A
and B and 0 levels of C . Since all three transitions have the same label, they synchronise, and when they do, the resulting
transition occurs with a rate that is the product of the individual rate expressions, i.e. e1∗ e2∗ e3. The exact definition of the
rate expressions depends on the level of detail required in the model. For example, if we require mass action kinetics, then
we would define e1 = A ∗ h, e2 = B ∗ h, and e3 = r/h. We note that for the purposes of this study we do not require exact
mass action kinetics in our models and we simply use the (multiplicative) identity (constant) 1 for all rate expressions.
Synchronisation, renaming and hiding. In general, synchronisation between modules is parameterised by labels as follows.
GivenmodulesM1 andM2, and set of labels L,M1 |[L]|M2 denotes the concurrent composition ofM1 andM2, synchronising
on all labels in L. If the label set is omitted, i.e.M1 ||M2, thenM1 synchroniseswithM2 on the intersection of labels occurring
inM1 andM2. PRISM also allows renaming of labels, denoted thusM1 {old_label ← new_label}, and hiding, denoted thus
M \ {label1, . . . , labeln}. Hidden labels are not available for synchronisation.
3.2. PRISM language extensions
The PRISMmodelling language does not include all the abstractions required for genericmodules.We therefore introduce
two extensions to make the language more convenient for modelling — they do not add any expressive power to the
language.
Variable Sharing. We require two ormoremodules to reference and update the same variable.We cannot use a PRISM global
variable for this purpose because they cannot be updated within a labelled transition. So, we use PRISM local variables and
introduce new syntax as follows: M1 |[L, V ]| M2, where V = {(v1, w1), . . . , (vn, wn)}. (vi, wi) is called a variable sharing
where vi (local toM1) andwi (local toM2) are shared.We implement a variable sharing (vi, wi) in PRISMby a pre-processing
step in which we substitute wi for vi. For each command r in M1, we remove all references to vi from r and define a new
command r inM2, replacing vi with wi; we then synchroniseM1 andM2 over r . We assume that the PRISM modules have
the same number of levels N for all variables and so the ranges of the shared variables are the same. The initial value of the
shared variable is max(init(vi), init(wi)) where init(var) is the initial value of the variable var . Because we can now share
variables between twomodules, we extend the hide operator to hide local variables so that they are unavailable for sharing.
Hence we can hide labels and variables in a module thusM \ {label1, . . . , labeln, var1, . . . , varn}.
2 Different choices of h for different species are possible, but only in very restricted circumstances.
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Fig. 3. Three generic pathway modules: Receptor, 3-stage Cascade and Gene Expression.
module Receptor
R : [0..1] init 1; L : [0..1] init 1; R* : [0..1] init 0;
[r1] R = 1 & L = 1 & R* = 0 -> 1:(R’ = 0) & (L’ = 0) & (R*’ = 1);
[r2] R* = 1 -> 1:true;
endmodule
module 3StageCascade
X : [0..1] init 1; X* : [0..1] init 0;
Y : [0..1] init 1; Y* : [0..1] init 0;
Z : [0..1] init 1; Z* : [0..1] init 0;
[r3] X = 1 & X* = 0 -> 1:(X’ = 0) & (X*’ = 1);
[r4] Y = 1 & Y* = 0 & X* = 1 -> 1:(Y’ = 0) & (Y*’ = 1);
[r5] Z = 1 & Z* = 0 & Y* = 1 -> 1:(Z’ = 0) & (Z*’ = 1);
[r6] Z* = 1 -> 1:true;
endmodule
module GeneExpression
Gene : [0..1] init 1; Protein : [0..1] init 0;
[r7] Gene = 1 & Protein = 0 -> 1:(Gene’ = 0) & (Protein’ = 1);
endmodule
Fig. 4. The three generic modules in PRISM with N = 1.
Synchronisation Within Modules. We will also require synchronisations involving labelled transitions within the same
module. For example, suppose we have two labels r1 and r2 in module M1. Renaming one by the other will not force a
synchronisation.M1 {r2 ← r1}will create two r1 labels inM1, and a non-deterministic choice between the labels. So, we
simply assume an alternative semantics for renaming when the labels are in the samemodule. With the new semantics, our
exampleM1 {r2 ← r1}means synchronise r1 and r2, which we implement by pre-processing (to form a single transition
r1 that is the conjunction of the transitions for r1 and r2).
4. Modelling a pathway
We define a generic pathway module to be a behavioural pattern within a pathway. For example, commonly occurring
pathway modules are Receptor, 3-stage Cascade and Gene Expression (Fig. 3).
The Receptor module has three species (L for ligand, R for receptor and R∗ for active receptor) and two reactions (r1 and
r2). The 3-stage Cascade module has 3 species (proteins X, Y and Z) and 4 reactions (r3, r4, r5 and r6). The Gene Expression
module has 2 species (Gene and Protein) and one reaction (r7).While Gene is not strictly a biochemical species, formodelling
purposes we treat it as a species. We use shading to indicate species with initial concentrations (the species present in the
initial state).
We represent the three generic pathway modules as PRISM modules with N = 1 in Fig. 4.3
We treat these modules as generic, that is, we instantiate them (strictly, duplicate and rename in PRISM) for multiple
occurrences. We adopt the following convention. For generic module M , Mi denotes an instance of M with every variable
and reaction renamed by an indexed form. For example, variable v becomes v1 in moduleM1.
3 PRISM reserves certain names such as X and does not allow nameswith the ∗ symbol — strictly we use names such as XInactive instead of X and XActive
instead of X∗ .
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Fig. 5. The two pathways Pathway1 and Pathway2 each comprise three instances of the generic pathway modules Receptor, 3-stage Cascade and Gene
Expression. External reactions and variables are denoted by black lines, internal reactions and variables by grey lines and species that are present in the
initial state by shaded ellipses.
We can compose modules synchronising over sets of labels as follows. Synchronising reaction a in module A with b in
module B is achieved by renaming a to b and synchronising the modules over b, i.e. A {a ← b} |[b]| B. In this paper we use
the term label and reaction synonymously.
A pathway is a parallel composition of instances of generic modules, renaming reactions to coordinate synchronisation
within the pathway.
Definition 3 (Pathway). Let G be a set of generic modules. A pathway P has the form (X1f1 |[L1]| . . . |[Ln−1]| Xnfn) \ H
where X1 . . . Xn are instances of modules in G, f1 . . . fn are sets of renamings, L1 . . . Ln−1 are labels (reactions) and H is a
set of hidings.
Definition 4 (Renaming Pathway Reactions). The reactions in a pathway P can be renamed creating a new pathway P ′ =
P {renamings}where renamings is a set of renamings.
As an example, consider pathway Pathway1 comprising instances of the Receptor, 3-stage Cascade and Gene Expression
modules:
Pathway1 = (Receptor1 {r21 ← r31}
|[r31]|
3StageCascade1 {r61 ← r71}
|[r71]|
GeneExpression1)
\ {r11, r31, r41, r51, R1, L1, R∗1,Gene1, Protein1}.
Receptor1 and 3StageCascade1 modules synchronise on r21 and r31, and 3StageCascade1 and GeneExpression1 synchronise
on r61 and r71 (strictly, we rename r21 to r31 and synchronise themodules on r31, and similarly for r61 and r71). Because of
these synchronisations, the active receptor catalyses the activation of protein X and active protein Z catalyses the expression
of Gene. Reactions r11, r31, r41 and r51 and variables R1, L1, R∗1 , Gene1 and Protein1 are hidden using the \ operator.
Reactions and (local) variables are considered to be external or internal.
Definition 5 (External Reactions and Variables). For a pathway P , the set of external reactions, extr(P), is the set of reactions,
modulo renamings, that have not been hidden and the set of external variables, extv(P), is the set of (local) variables that
have not been hidden. External reactions are available for synchronisation and external variables are available for sharing.
Hence, extr(Pathway1) = {r71} and extv(Pathway1) = {X1, Y1, Z1, X∗1 , Y ∗1 , Z∗1 }.
As a further example we define pathway Pathway2:
Pathway2 = (Receptor2 {r22 ← r32}
|[r32]|
3StageCascade2 {r62 ← r72}
|[r72]|
GeneExpression2)
\ {r12, r32, r42, r52, R2, L2, R∗2,Gene2, Protein2}
With extr(Pathway2) = {r72} and extv(Pathway2) = {X2, Y2, Z2, X∗2 , Y ∗2 , Z∗2 }.
Pathways Pathway1 and Pathway2 are shown graphically in Fig. 5.
We now consider networks of pathways.
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Fig. 6. The four types of auxiliary reactions, two are reactions and two are modifiers.
5. Modelling a network of independent pathways
Herewegive the general definition of a network, and then consider the special case of networks of independent pathways.
Later we consider networks with cross-talk.
A network is a parallel composition of pathways, with optional synchronisation of external reactions and sharing of
variables between pathways.
Definition 6 (Network). A network is a composition of two pathways of the form P1 {renamings1} |[E ∪ U, V ]|
P2 {renamings2} where |[E ∪ U, V ]| defines the interaction between P1 and P2. renamings1 and renamings2 are optional
sets of renamings of reactions. E = extr(P1 {renamings1}) ∩ extr(P2 {renamings2}), in other words, E is the intersection
of the sets of external reactions, modulo renamings, in P1 and P2. V is a set of variable sharings between P1 and P2.
U ⊆ extr(P1 {renamings1}) ∪ extr(P2 {renamings2}).
Note, P1, P2, renamings1, renamings2, U and V determine the network.
Now consider the special case of a network of independent pathways.
Definition 7 (Independent Pathways). A network of two pathways P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2} is
independent if there is no synchronisation of reactions and sharing of variables between the pathways, hence E = ∅ and
V = ∅.
We can compose our two example pathways independently thus:
Pathway1 |[E ∪ U, V ]| Pathway2 where E = V = U = ∅.
We now turn our attention to the case where there is synchronisation of reactions or sharing of variables between the
pathways, i.e. there is cross-talk. However, before doing so we introduce the concept of auxiliary reactions, and ultimately
how they result in unused reactions, i.e. the set U .
6. Auxiliary reactions
Auxiliary reactions are additional basic reactions and modifiers that can be used to express interactions between
pathways.
Definition 8 (Auxiliary Reactions). There are four types of auxiliary reactions for a species X as given in Fig. 6.
Production and degradation reactions are the two basic reactions for any species. All other reactions can be defined
by synchronising production and degradation reactions. For example, we can express the formation of Z from X and Y by
synchronising the degradation of X and Y with the production of Z .
Catalysis and inhibition are modifiers: they change the (PRISM) condition of reactions. Catalysis and inhibition auxiliary
reactions must synchronise with a reaction to make (biological) sense.
For any species X we can add any number of any type of auxiliary reactions.
Definition 9 (PRISM Implementation). For any species X in a module, for any i, any of the 4 types of auxiliary reactions can
be added as follows:
[prod_i] X = 0 -> 1:(X’ = 1);
[deg_i] X = 1 -> 1:(X’ = 0);
[cat_i] X = 1 -> 1:true;
[inhib_i] X = 0 -> 1:true;
Note, althoughwe have not defined an explicit syntax for adding auxiliary reactions, we assume for any given pathway P
wecan augment itwith a given set of auxiliary reactions aux(P). For a pathway P there is an infinite number of augmentations
of auxiliary reactions.
Definition 10 (Pathway Auxiliary Reactions). For a given pathway P , the set of auxiliary reactions is aux(P) and we extend
extr(P) to include aux(P), i.e. all auxiliary reactions are external.
We add to our two example pathways some auxiliary reactions, themotivation for thesewill be given in the next section.
We adopt the following convention. In Pathwayj we label auxiliary reaction i as aij (or ai_j in PRISM).
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Fig. 7. The two pathways Pathway1 and Pathway2 with added auxiliary reactions.
In the Receptor module in Pathwayj we add:
[a1_j] R = 1 -> 1:(R’=0);
[a2_j] R* = 0 -> 1:(R*’ = 1);
[a3_j] L = 0 -> 1:(L’ = 1);
In the 3-stage Cascade module in Pathwayj we add:
[a4_j] X* = 1 -> 1:true;
[a5_j] Y = 1 -> 1:(Y’=0);
[a6_j] Y* = 0 -> 1:(Y*’=1);
[a7_j] Z* = 0 -> 1:true;
In the Gene Expression module in Pathwayj we add:
[a8_j] Protein = 1 -> 1:(Protein’ = 0);
The pathways with added auxiliary reactions are shown graphically in Fig. 7.
Auxiliary reactions are an integral part of modelling cross-talk. We model cross-talk by different combinations of
synchronisation of external reactions (which includes the auxiliary reactions) and sharing of variables.
Definition 11 (Cross-talk). Given a network of two pathways P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2}, there is cross-
talk if there is at least one reaction e ∈ E or one variable sharing v ∈ V . The number of cross-talks is |E| + |V |.
We now introduce the concept of unused reactions U with the aid of the following functions.
Definition 12 (Mapped). Given a network of two pathways P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2}, for any e ∈ E,
we define the function mapped(e) = {xi|xi ← e} ∪ {ui|ui ← e} where renamings1 = {x1 ← y1, . . . , xn ← yn} and
renamings2 = {u1 ← v1, . . . , un ← vn}. We also define mapped(E) = e∈E mapped(e). In other words, mapped(e) is the
set of reactions involved in one synchronisation e between the pathways and mapped(E) is the set of reactions involved in
any synchronisation e ∈ E between the pathways.
The unused reactions U are the auxiliary reactions that are not used for synchronisation between two pathways, and
so U = (aux(P1) ∪ aux(P2)) \ mapped(E). Note that since each reaction in U occurs in only one pathway, they cannot
synchronise and their corresponding transitions never execute. This will be explored in detail in the next section, where we
turn our attention to a network of two pathways in which there is cross-talk.
7. Categorisation of cross-talk
Although there is some discussion of types of cross-talk [21], there appears to be no universal categorisation in the
literature. In this section we propose that there are five types of cross-talk: substrate availability, signal flow, receptor
function, gene expression and intracellular communication. We note that four of the five types are alluded to in [22] but
are not made specific.
We give the motivation for the five types using indicative examples from the literature. We define several functions that
are used in the formalisation. We then formalise the types and prove that the types are distinct. Finally, we give examples
of each type of cross-talk using our example pathways Pathway1 and Pathway2.
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7.1. Motivation for types
In this sectionwe give evidence of each of the five types.While there is no proof that there are no other types of cross-talk,
we have found no examples after performing an exhaustive literature search and discussing this with domain experts.
Substrate availability cross-talk In [13] there are two pathways that compete for activation of the MAPK cascade. The
pathways share the MAPKKK protein STE11 and have homologous MAPKK and MAPK proteins.
Signal flow cross-talk In [10] there is signal flow cross-talk between the MAPK and Integrin signalling pathways.
Activation of the Integrin pathway enhances signalling through the MAPK pathway by increased rate of activation of key
proteins in the pathway.
Receptor function cross-talk In [23] other signalling pathways can activate the Oestrogen receptor in the absence of the
Oestrogen ligand.
Gene expression cross-talk In [24] two pathways contain cross-talk within the nucleus. One pathway contains a
transcription factor GR that resides outside the nucleus. Upon signalling, GR relocates to the nucleus and represses the
transcription factor NF-κB that is activated by another pathway.
Intracellular communication cross-talk In [21] the TGF-β and WNT pathways reciprocally regulate the production of
their ligands. There is some contention in the literature as to whether this is genuine cross-talk: the interaction is less direct
than other types of cross-talk and involves lengthy processes such as gene expression and ligand excretion.
We now turn to formalising the 5 types, but before doing so, we define several useful functions on the generic
modules.
7.2. Functions on modules
We define several functions that operate on modules, of type func : Module → {Labels}.
all — all reactions
all(Receptor) = {a1, a2, a3, r1}
all(3StageCascade) = {a4, a5, a6, a7, r3, r4, r5}
all(GeneExpression) = {a8, r7}
trans — all transformation reactions
trans(Receptor) = {a1, a2, a3, r1}
trans(3StageCascade) = {a5, a6, r3, r4, r5}
trans(GeneExpression) = {a8, r7}
mod — all modifiers
mod(Receptor) = ∅
mod(3StageCascade) = {a4, a7}
mod(GeneExpression) = ∅
Note that ∀x.all(x) = trans(x) ∪mod(x).
catalysis — all catalysis reactions
catalysis(Receptor) = ∅
catalysis(3StageCascade) = {a4}
catalysis(GeneExpression) = ∅
inhib — all inhibition reactions
inhib(Receptor) = ∅
inhib(3StageCascade) = {a7}
inhib(GeneExpression) = ∅
prod — all production reactions
prod(Receptor) = {a2, a3}
prod(3StageCascade) = {a6}
prod(GeneExpression) = ∅
deg — all degradation reactions
deg(Receptor) = {a1}
deg(3StageCascade) = {a5}
deg(GeneExpression) = {a8}
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receptor_deg — all degradation of (inactive) receptor reactions
receptor_deg(Receptor) = {a1}
receptor_deg(3StageCascade) = ∅
receptor_deg(GeneExpression) = ∅
receptor_act — all ligand-receptor binding reactions
receptor_act(Receptor) = {r1}
receptor_act(3StageCascade) = ∅
receptor_act(GeneExpression) = ∅
active_receptor_prod — all production of active receptor reactions
active_receptor_prod(Receptor) = {a2}
active_receptor_prod(3StageCascade) = ∅
active_receptor_prod(GeneExpression) = ∅
ligand_prod — all production of ligand reactions
ligand_prod(Receptor) = {a3}
ligand_prod(3StageCascade) = ∅
ligand_prod(GeneExpression) = ∅
gene_expression — all gene expression reactions
gene_expression(Receptor) = ∅
gene_expression(3StageCascade) = ∅
gene_expression(GeneExpression) = {r7}.
7.3. Cross-talk types
We now formalise the 5 types of cross-talk: substrate availability, signal flow, receptor function, gene expression and
intracellular communication, in terms of the three modules introduced so far. Extending the formalisation to include extra
modules that behave in a similar way is trivial.
Given a network of the form P1 {renamings1} |[E ∪ U, V ]|P2 {renamings2}, a cross-talk is either a e ∈ E or a v ∈ V .
A cross-talk v ∈ V is always substrate availability cross-talk.
A cross-talk e ∈ E is categorised according to the rules below. Rules are either necessary rules or biological constraints.
Biological constraints prevent infeasible cross-talk due to, for example, different cellular locations or different species types.
These constraints concern which reactions can be synchronised between two pathways, thus a constraint always concerns
members ofmapped(e).
We use the notation Module_Type ∈ Pi to mean a module in Pi of type Module_Type. The operator ∃!x.f (x) is defined by
∃x.(f (x) ∧ ∀y.(f (y)→ y = x)).
Finally, we note by the definition of E in a network the following properties hold.
• ∀e ∈ E.∀x ∈ mapped(e).(x ∈ P1 ∨ x ∈ P2)
• ∀e ∈ E.∃x ∈ mapped(e).(x ∈ P1)
• ∀e ∈ E.∃x ∈ mapped(e).(x ∈ P2).
Signal flow cross-talk
e is signal flow cross-talk if and only if the rules in Case 1 or Case 2 hold.
Case 1: P1 affects a transformation reaction in P2 or vice-versa.
Rules
∃x ∈ mapped(e).∃3StageCascade ∈ (P1 ∪ P2).x ∈ trans(3StageCascade)
Biological constraints
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∉ trans(Receptor)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∉ all(GeneExpression)
Case 2: P1 produces a protein in P2 or vice-versa, or else P2 catalyses P1’s production of a protein, or vice-versa, or P2
inhibits P1 from producing a protein, or vice-versa.
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Rules
∃!x ∈ mapped(e).∃GeneExpression ∈ (P1 ∪ P2).x ∈ deg(GeneExpression)
∃!x ∈ mapped(e).∃3StageCascade ∈ (P1 ∪ P2).x ∈ prod(3StageCascade)
Biological constraints
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∉ all(Receptor)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∈ trans(3StageCascade)
→ x ∈ prod(3StageCascade)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∈ all(GeneExpression)
→ x ∈ deg(GeneExpression)
Receptor function cross-talk
e is receptor function cross-talk if and only if the rules in Case 1, Case 2 or Case 3 hold.
Case 1: P1 catalyses P2’s receptor degradation, or vice-versa, with possible modifiers from 3-stage cascades.
Rules
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ receptor_deg(Receptor)
∃x ∈ mapped(e).∃3StageCascade ∈ Pj.x ∈ catalysis(3StageCascade)
where i ≠ j
Biological constraints
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∉ all(GeneExpression)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∉ trans(3StageCascade)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ x ∈ receptor_deg(Receptor)
Case 2: The activation of P1’s receptor is inhibited by P2, or vice-versa, with possible extra modifiers from 3-stage
cascades.
Rules
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ receptor_act(Receptor)
∃x ∈ mapped(e).∃3StageCascade ∈ Pj.x ∈ inhib(3StageCascade)
where i ≠ j
Biological constraints
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∉ all(GeneExpression)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∉ trans(3StageCascade)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ x ∈ receptor_act(Receptor)
Case 3: P1’s receptor is activated without the need for a ligand and this is catalysed by P2, or vice-versa, with possible
extra modifiers from 3-stage cascades.
Rules
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ receptor_deg(Receptor)
∃!x ∈ mapped(e).∃Receptor ∈ Pi.x ∈ active_receptor_prod(Receptor)
∃x ∈ mapped(e).∃3StageCascade ∈ Pj.x ∈ catalysis(3StageCascade)
where i ≠ j
Biological constraints
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∉ trans(3StageCascade)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∉ all(GeneExpression)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ (x ∈ receptor_deg(Receptor) ∨ x ∈ active_receptor_prod(Receptor))
Gene expression cross-talk
The rate of P1’s gene expression reaction is modified by a species in a 3-stage cascade module in P2 or vice-versa.
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Rules
∃!x ∈ mapped(e).∃GeneExpression ∈ (P1 ∪ P2).
x ∈ gene_expression(GeneExpression)
∃x ∈ mapped(e).∃3StageCascade ∈ (P1 ∪ P2).x ∈ mod(3StageCascade)
Biological constraints
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∉ all(Receptor)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∉ trans(3StageCascade)
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∈ all(GeneExpression)
→ x ∈ gene_expression(GeneExpression)
Intracellular communication cross-talk
A protein is released from P1 that is the ligand for P2, or vice-versa, with possible extra modifiers from 3-stage cascades.
Rules
(∃!x ∈ mapped(e).∃GeneExpression ∈ Pi.x ∈ deg(GeneExpression))∨
(∃!x ∈ mapped(e).∃3StageCascade ∈ Pi.x ∈ deg(3StageCascade))
∃x ∈ mapped(e).∃Receptor ∈ Pj.x ∈ ligand_prod(Receptor)
where i ≠ j
Biological constraints
∀x ∈ mapped(e).∀GeneExpression ∈ (P1 ∪ P2).x ∈ all(GeneExpression)
→ x ∈ deg(GeneExpression)
∀x ∈ mapped(e).∀3StageCascade ∈ (P1 ∪ P2).x ∈ trans(3StageCascade)
→ x ∈ deg(3StageCascade)
∀x ∈ mapped(e).∀Receptor ∈ (P1 ∪ P2).x ∈ all(Receptor)
→ x ∈ ligand_prod(Receptor)
7.4. Categorisation is well-defined
We prove below that the categorisation is well-defined, i.e. that any cross-talk that has been categorised has only one
type.
Theorem 1. Categorisation is well-defined.
Proof. Trivially, any cross-talk v is of type substrate availability cross-talk.
We now in turn assume a cross-talk e of each type and give awitness, a label that must/must not be part of the cross-talk,
that prevents it from being another type of cross-talk.
Suppose e has been categorised as signal flow cross-talk. In both cases of signal flow cross-talk, no transformation
reactions from a Receptor module are allowed inmapped(e), hence x ∈ {a1, a2, a3, r1} → x ∉ mapped(e).
A receptor function cross-talk must have a label from receptor_deg(Receptor) (Case 1 and Case 3) or a label from
receptor_act(Receptor) (Case 2). Therefore, a1 ∈ mapped(e) ∨ r1 ∈ mapped(e).
The witness to e not being a receptor function cross-talk is a1 ∉ mapped(e) and r1 ∉ mapped(e).
Assuming e is each type of cross-talk in turn, we list below the witnesses that prove e can have no other type.
e is signal flow cross-talk Witness
cannot be receptor function ∀x ∈ {a1, r1}.x ∉ mapped(e)
cannot be gene expression r7 ∉ mapped(e)
cannot be intracellular communication a3 ∉ mapped(e)
e is receptor function cross-talk Witness
cannot be signal flow ∀x ∈ {a5, a6, r3, r4, r5}.
x ∉ mapped(e)
cannot be gene expression r7 ∉ mapped(e)
cannot be intracellular communication a3 ∉ mapped(e)
e is gene expression cross-talk Witness
cannot be signal flow ∀x ∈ {a5, a6, r3, r4, r5}.
x ∉ mapped(e)
cannot be receptor function ∀x ∈ {a1, r1}.x ∉ mapped(e)
cannot be intracellular communication a3 ∉ mapped(e)
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e is intracellular communication cross-talk Witness
cannot be signal flow a3 ∈ mapped(e)
cannot be receptor function ∀x ∈ {a1, r1}.x ∉ mapped(e)
cannot be gene expression r7 ∉ mapped(e)

7.5. Examples of cross-talk
Given two pathways, we can generate all possible instances of cross-talk; the algorithm is given in the Appendix, it
depends upon k, the maximum number of synchronisations on a reaction. Applying the algorithm to our two example
pathways, Pathway1 and Pathway2, with k = 3, yields 757 candidate examples of cross-talk (that do not necessarily
satisfy the biological constraints) and 175 actual examples of cross-talk. The latter are categorised as follows: 36 substrate
availability, 65 signal flow, 18 receptor function, 28 gene expression, and 28 intracellular communication. Below, we give
an example from each type.
Substrate availability cross-talk The pathways compete for activation of protein X , hence the pathways share variables
X1 and X2.
Pathway1 |[E ∪ U, V ]| Pathway2
where U = aux(Pathway1) ∪ aux(Pathway2), E = ∅ and V = {(X1, X2)}. This example is shown in Fig. 8(a).
Signal flow cross-talk An alternative reaction to activate Y1 through the X∗2 enzyme. Synchronise a51, the degradation
of Y1, with a61, the production of Y ∗1 to create the reaction4 Y1 → Y ∗1 , and also synchronise with a42, the enzymatic activity
of X∗2 .
Pathway1 {a51 ← rnew, a61 ← rnew} |[E ∪ U, V ]| Pathway2 {a42 ← rnew}
whereU = aux(Pathway1) ∪ aux(Pathway2) \ {a51, a61, a42}, E = {rnew} and V = ∅. This example is shown in Fig. 8(b).
Receptor function cross-talk An alternative reaction to activate receptor R2 by the enzyme X∗1 . Synchronise a12, the
degradation of receptor R2, with a22, the production of the active receptor R∗2 to create the reaction R2 → R∗2 , and also
synchronise a41, the enzymatic activity of X∗1 .
Pathway1 {a41 ← rnew} |[E ∪ U, V ]| Pathway2 {a12 ← rnew, a22 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a41, a12, a22}, E = {rnew} and V = ∅. This example is shown in Fig. 8(c).
Gene expression cross-talk Inhibit the expression of Gene1 by the Z∗2 protein. Synchronise a72, the inhibiting activity of
Z∗2 , with r71, the expression of Gene1.
Pathway1 {r71 ← rnew} |[E ∪ U, V ]| Pathway2 {a72 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a72, r71}, E = {rnew} and V = ∅. This example is shown in Fig. 8(d).
Intracellular communication cross-talk The output of expressing Gene1 is the ligand for Pathway2. Synchronise a81,
the degradation of Protein1, with a32, the production of the ligand L2 to create the reaction Protein1 → L2.
Pathway1 {a81 ← rnew} |[E ∪ U, V ]| Pathway2 {a32 ← rnew}
where U = aux(Pathway1) ∪ aux(Pathway2) \ {a81, a32}, E = {rnew} and V = ∅. This example is shown in Fig. 8(e).
7.6. Higher order networks
We have defined how to model networks of two pathways. Higher order networks can be modelled by composing a
network with a single pathway, hence:
Network2 = Pathway1 |[E1 ∪ U1, V1]| Pathway2
Network3 = Network2 |[E2 ∪ U2, V2]| Pathway3
. . .
Networki = Networki−1 |[Ei−1 ∪ Ui−1, Vi−1]| Pathwayi.
However, to the best of our knowledge all cross-talk are between pairs of pathways. Our definition of a network allows a
single cross-talk in which three or more pathways participate, however no biological examples of such an interaction have
been reported.
This concludes modelling cross-talk. We now switch our focus from defining and categorising cross-talk in a rigorous
way to analysing models of cross-talk using logical properties.
8. Detecting cross-talk
So far we have discussed themain contribution of this paper, how tomodel cross-talk in a rigorous way by looking at the
form of the model description, e.g. the synchronisations between PRISM modules. We now give preliminary results on the
4 Notice that this is synchronisation within a module.
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Fig. 8. An example of each of the five types of cross-talk: (a) two pathways compete for a protein, (b) a pathway up-regulates signal flow through another
pathway, (c) a pathway activates the receptor of another pathway in the absence of a ligand, (d) two pathways have conflicting transcriptional responses,
(e) a pathway releases a ligand for another pathway.
complementary problem, how to analyse at the model level (i.e. at the level of the CTMC rather than the form of the model
description5). We aim to both detect and characterise cross-talk, we first tackle detecting cross-talk in these models.
This section makes use of the two pathways Pathway1 and Pathway2 introduced in Section 4 and the five example cross-
talk models of Section 7.5.
The presence of cross-talk can be detected by checking a set of temporal logic properties as follows.
5 For example, we define CTMCs in PRISM using the PRISM languagewhereas in a tool like Matlab, we would define them with equations.
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Table 1
The change in probability for each of the 5 cross-talkmodels comparedwith
the independent pathways model for the three CSL properties.
ψ1 ψ2 ψ3
Substrate availability example = ↓ ↓
Signal flow example ↑ ↑ =
Receptor function example ↓ = ↑
Gene expression example ↓ ↓ =
Intracellular communication example = = =
We choose CSL because we need a quantitative logic — it is a change in the probability of a formula being true that allows
us to detect the presence of a cross-talk. The probabilities are used to measure the number of paths that satisfy a property.
For example, in the signal flow cross-talk example (compared to the independent model) there is a greater number of paths
to the expression of Protein1. There are other ways to detect cross-talk, however we use model checking of CSL properties
as it is relatively straightforward and familiar to a large part of the community.
Given pathways Pathway1 and Pathway2 that conclude with gene expression (Protein1 and Protein2 being produced
respectively), we detect cross-talk by comparing the probabilities of the following three CSL formulae with the probability
of independent composition. Namely, we compare probabilities for the five example cross-talk models of Section 7.5 with
Pathway1 {renamings1} |[E ∪ U, V ]| Pathway2 {renamings2} where E = ∅ and V = ∅. In each case, cross-talk is indicated
by a change of probability of at least one formula.
Competitive Signal Flow (Pathway1 before Pathway2): probability of signal flow through Pathway1 before Pathway2
ψ1 = P=? [ F (Protein1 = 1 ∧ Protein2 = 0) ]
Independent Signal Flow (Pathway1): probability of signal flow through Pathway1 within a time bound (3 time units)
ψ2 = P=? [ F≤3 (Protein1 = 1) ]
Independent Signal Flow (Pathway2): probability of signal flow through Pathway2 within a time bound (3 time units)
ψ3 = P=? [ F≤3 (Protein2 = 1) ]
The change in probability for each of the 5 cross-talk models, as compared to the independent pathways, is given in
Table 1. ↑ denotes an increase, ↓ denotes a decrease and = denotes no change in probability. Results were obtained using
the PRISM model checker (run times are negligible).
Notice that there is no change in probability for the intracellular communication cross-talk model. In our qualitative
model of this cross-talk, one pathway produces a ligand for another pathway only after the original ligand molecule has
been consumed in a reaction. This means that the cross-talk has no effect on the rate of the activation reactions in either
pathway. In a model with a greater level of quantitative detail, as discussed in Section 11, this cross-talk would change the
rate of the activation reactions. This result is not unexpected as we have already identified that intracellular communication
cross-talk is a source of contention in the literature.
We now move on to characterising cross-talk in models in which there is no model description.
9. Characterising cross-talk
The type of cross-talk can be characterised at the model level using different temporal logic properties.
We choose CTL because we need a qualitative logic — it is a difference in the structure of the Markov chain rather
than the transition rates that allows us to distinguish between types of cross-talks. We define 5 CTL properties, each of
which characterises a type of cross-talk. The properties are simple liveness or safety properties and do not exploit the rate
information in the model.
As before, the activation of a pathway is reflected by the expression of Protein. This is checked by evaluating the
proposition (Protein = 1).
Substrate availability example (Pathway1 and Pathway2 compete for a protein). It is not possible to activateX in both pathways
(i.e. the pathways compete for a limited protein).
A G ¬ (X∗1 = 1 ∧ X∗2 = 1)
Signal flow example (flow from Pathway2 to Pathway1). It is possible to activate Pathway1 without activating receptor R1.
E F (R∗1 = 0 ∧ Protein1 = 1)
Receptor function example (Pathway1 activates Pathway2’s receptor). It is possible to activate the receptor R2 without using
the ligand L2.6
E F (R∗1 = 0 ∧ R∗2 = 1 ∧ L2 = 1)
6 We include R∗1 = 0 because signalling in Pathway1 in the intracellular communication model can produce L2 .
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Fig. 9. Cross-talk between the TGF-β , WNT and MAPK pathways. Species that are present in the initial state are denoted by shaded ellipses.
Gene expression example (Pathway2 inhibits Pathway1’s gene expression). It is not possible to activate Pathway1 if the signal
has already passed through Pathway2.
A G¬ (Protein1 = 1) {Y ∗1 = 1 ∧ Z∗1 = 0 ∧ Protein∗2 = 1}
Intracellular communication example (Pathway1 expresses Pathway2’s ligand). It is possible to use and replenish ligand L2.
E (L2 = 1) U ( (L2 = 0) ∧ E (L2 = 0) U (L2 = 1) )
We now demonstrate our approach on a prominent case-study of the cross-talk between the TGF-β , WNT and MAPK
pathways.
10. Case-study
We apply our approach to a prominent biological case-study of the cross-talk between the TGF-β , WNT and MAPK
pathways. Details are taken from [21] and from discussions with a domain expert [25]. We use the approach to classify
the cross-talk in the model and to understand the effects of the cross-talk on the TGF-β pathway. We note that the effects
of cross-talk are not discussed in [21].
Our model of the pathways and their cross-talk is shown in Fig. 9. To apply our modelling approach we need to expand
our set of modules to: Receptor, Protein Activation, 2-stage Cascade, 3-stage Cascade, Translocation, Protein Binding and
Gene Expression. This is a natural extension of our approach. The extra modules act in a similar manner to the modules that
have been discussed and so the extension of the formalisation from Section 7.3 is trivial.
We define the following three pathways (for brevity, we omit the synchronisation sets and renamings).
MAPK = (Receptor {. . .} |[. . .]| ProteinActivation {. . .} |[. . .]|
Cascade3 {. . .} |[. . .]| Cascade2 {. . .} |[. . .]|
Translocation {. . .} |[. . .]| Translocation)
TGFB = (Receptor {. . .} |[. . .]| ProteinActivation {. . .} |[. . .]|
ProteinActivation {. . .} |[. . .]| ProteinBinding {. . .}
|[. . .]| Translocation {. . .} |[. . .]| GeneExpression {. . .}
|[. . .]| GeneExpression)
WNT = (Receptor {. . .} |[. . .]| ProteinActivation {. . .} |[. . .]|
Translocation {. . .} |[. . .]| GeneExpression)
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As indicated in Fig. 9, the following auxiliary reactions are added. In the MAPK pathway we add catalysis auxiliary
reactions to the MAPK∗, AKT∗ and TF∗ species. In the TGF-β pathway we add degradation auxiliary reactions to the Smad4
and Smad7 species. In the WNT pathway we add catalysis auxiliary reactions to the Axin and β-Catenin∗ species.
We then consider four networks, TGFB, TGFB |[. . .]|MAPK , TGFB |[. . .]|WNT and (TGFB |[. . .]|MAPK) |[. . .]|WNT , referred
to as the full network.
We detect the presence of 9 cross-talks in the full network using the approach outlined in Section 9 — no new cross-talks
are identified compared with the literature. We then characterise each cross-talk using the approach outlined in Section 8
and find that there are three types of cross-talk in the model, as follows.
We measure the output of the TGF-β pathway by the activity of the expression of Proteins (a set of proteins in the TGF-β
pathway). We use the following CSL properties to compare the effects of cross-talk:ψ1, the eventual expression of Proteins,
and ψ2, the time-dependent expression of Proteins (within 5 time units).
ψ1 = P=? [ F (Proteins = 1) ]
ψ2 = P=? [ F≤5 (Proteins = 1) ]
We follow with a detailed analysis of each of the four networks.
Independent network. In the independent network, TGFB, the activation of the TGF-β pathway leads to the expression of
Proteins within 5 time units, ψ2, with probability 0.47 and to the eventual expression of Proteins, ψ1, with probability< 1
due to the inactivation of the receptor.
TGF-β and MAPK Cross-talk. In the TGF-β and MAPK network, TGFB |[. . .]| MAPK , there are two types of cross-talk. Signal
flow:MAPK∗ proteins slow signal flow through the TGF-β pathway by deactivating the R-Smads and degrading Smad4. Gene
expression: the TF∗ and AKT∗ proteins upregulate gene expression in the TGF-β pathway. Note that the appearance of the
AKT and PI3K proteins in the MAPK pathway indicates an implicit cross-talk with the AKT and PI3K pathways respectively.
The inclusion of cross-talk with the MAPK pathway can both provide alternative gene expression reactions and block signal
flow through the TGF-β pathway, overall causing the probability of the expression of Proteins within 5 time units, ψ2, to
increase to 0.73. The probability of the eventual expression of Proteins,ψ1, is 1 because the reactions in the MAPK pathway
are not inhibited in the model.
TGF-β and WNT cross-talk. In the TGF-β and MAPK network, TGFB |[. . .]| WNT , there are three types of cross-talk. Signal
flow: the Smad7∗ protein degrades β-Catenin and the Axin protein degrades Smad7. Gene expression: the β-Catenin protein
upregulates gene expression in the TGF-β pathway. Intracellular communication: theWNTpathway can cause the production
of a ligand for the TGF-β pathway, and vice-versa. The inclusion of cross-talk with the WNT pathway can both provide an
alternative gene expression reaction and inhibit Smad7 which can inactivate the receptor for the TGF-β pathway. Overall
this causes the probability of the expression of Proteins within 5 time units, ψ2, to increase to 0.76. The probability of the
eventual expression of Proteins, ψ1, is still< 1 due to the degradation of the β-Catenin protein.
TGF-β , WNT and MAPK cross-talk. The TGF-β , WNT and MAPK network, (TGFB |[. . .]| MAPK) |[. . .]| WNT , is the union of
the two cross-talk scenarios above. The effect of both WNT and MAPK cross-talk to the TGF-β pathway is additive. The
probability of ψ2 rises to 0.88, compared with the single cross-talks of WNT and MAPK with probability 0.76 and 0.73
respectively. The inclusion of the MAPK cross-talk provides sets of reactions that cause gene expression which cannot be
inhibited and hence the probability of ψ1 is 1.
We remark that we have categorised the complicated cross-talk in which Axin degrades Smad7 unambiguously as signal
flow. Whereas, in [21] there is a suggestion that the cross-talk is receptor function because Axin degrades the receptor (via
Smad7, an intermediate). However, our approach does not classify this cross-talk as receptor function cross-talk.
11. Discussion
Reversible reactions. We have simplified the biochemistry in this paper by only considering irreversible reactions, e.g. the
activation reaction X → X∗. If our models were to include deactivation reactions, e.g. X∗ → X , then the temporal logic
properties would need to be strengthened. For example, the property characterising signal flow cross-talk expresses that at
some point in time R1 is inactive and Protein1 is expressed. If the activation of R1 is a reversible reaction then this property
is too weak. The property could be satisfied if R1 becomes active, Protein1 is expressed and then R1 becomes inactive. Thus,
the correct property with reversible reactions is:
E [(R∗1 = 0) U (R∗1 = 0 ∧ Protein1 = 1)].
Cross-talk formalisation. Our cross-talk formalisation depends on the set of modules being considered. One reason for this
is that the modules act as a proxy for the cellular location. For example, in the definition for Gene Expression cross-talk, we
disallow reactions from the Receptor module because gene expression occurs in the nucleus which is ‘far’ from the receptor.
Future work will be to introduce a formalisation that is not so strongly tied to current set of modules. We expect to need, at
the very least, a mapping from the set of modules to the location of the modules.
Cross-talk generation and pathway generation. Our method to generate all cross-talk models from a set of pathways (see the
Appendix) could also be applied to generate all pathway models from a set of modules. However, to generate a pathway
48 R. Donaldson, M. Calder / Theoretical Computer Science 456 (2012) 30–50
from a set of modules we would need to be careful that all modules are connected and sometimes connected together in
a specific manner. Therefore, we would require a constraint to our method: a set of reactions in each module that must
synchronise with at least one reaction in another module.
Quantitative detail. We have demonstrated our approach on models with a low level of quantitative detail. As such, the
probability values resulting from CSL model checking can only be used to compare the models with each other. However,
with more quantitative detail, further interpretation of our analysis results would be possible. For example, the properties
concerning the probability of time-dependent gene expression between cross-talk models would become a meaningful
assessment of the strength of the cross-talk.
Model-checking runtimes. The state spaces for all the models presented here are small, e.g. of the order of 102. Runtimes for
checking properties are therefore trivial.
Feature interaction. There is an interesting analogy with feature interactions in telecommunications and software systems.
Features, or services, in these systems are functionality additional to the core, added incrementally, by various developers, at
various times (e.g. due to market deregulation). One consequence of these uncoordinated additions is interactions between
the new features themselves, or with the core system, causing some features or the core to behave in new, sometimes
undesirable ways. One inspiration for the approach to pathway cross-talk presented here is work on using temporal logics
to detect and characterise feature interactions [26]. An open question is whether techniques developed to model and detect
features and interactions may be applicable to pathway cross-talk. For example, a common problem is lack of universal
definition of pathway/feature; it would be interesting to investigate if concepts such as the feature construct of [27] would
be useful in the pathway paradigm. Finally, we note that in telecommunications, 3-way feature interactions (a interaction
between three features, that does not occur between only two features) are very rare: most detection algorithms depend
on a pairwise analysis. This parallels cross-talk in which we have not found a single example of cross-talk that is between
three pathways.
Cross-talk categorisation. An interesting question that also plagues the feature interaction community is what is a feature
and a feature interaction? This is analogous to what is a pathway and a cross-talk, which begs the question, is our cross-talk
categorisation complete? We recall discussions with a domain expert [25] that suggest a pathway is a dominant behaviour
whereas cross-talk is a side effect, which leads us to believe this is future work for the biological, rather than the formal
computer science, community.
The Molecular Nose research project. This work has been developed as part of the Molecular Nose research project (see
Acknowledgements). The project aims to develop new in vivo sensor technologies for analysing and interpreting cellular
signal transduction networks. The term ‘‘molecular nose’’ refers to sensor technology ‘‘sniffing out’’ pathways within a cell.
Long term, we aim to generate hypotheses about the structure of pathways and networks that may explain cross-talks or
pathway structures, comparing those in normal cells with the same in diseased cells.
12. Conclusions and future work
We have defined a rigorous approach to modular modelling of pathways and their cross-talk, based on generic modules
and composition with synchronisation, variable sharing, and reaction renaming.
Our modelling style is reagent-centric, implemented in a state-based language, which means that every reagent is
mapped to a variable that denotes a concentration level in anunderlying CTMCwith levels.While in standard reagent-centric
modelling modules represent processes, here we define generic modules that represent commonly occurring behavioural
patterns in signalling pathways. We then compose instances of modules, using the standard (synchronising) parallel
composition operator, to define a pathway. Since composition is associative, this extends to pathways composed of any
number of modules.
A key aspect of a pathway is the distinction between external reactions and variables, that are visible in the interface,
and internal reactions and variables, that are not visible. We then compose instances of pathways, again using the standard
(synchronising) parallel composition operator, to define a network of pathways. If the intersection of the interfaces of the
two pathways is empty, then the two pathways are considered independent. The pathways can be ‘‘wired’’ together, i.e. to
make the pathways cross-talk, in a combinatorial manner by renaming and synchronising external reactions and by sharing
variables. Again, by associativity, this extends to networks of any number of pathways. Also, it is easy to remove any results
that are clearly biochemically infeasible. This approach allows us to both explore all possible cross-talks between pathways
and to explain a given network in terms of pathways.
We have defined 5 different types of cross-talk, these have been alluded to in the literature but not previously defined
formally. Generation of the different types of cross-talk is given by two simple algorithms; detection and characterisation of
the different types of cross-talk is by qualitative and quantitative logic propertymodel checking.We are able to show, from a
basic set of modules, that every type of cross-talk can be generated and detected. Throughout, we use the state based PRISM
modelling language, a language of guarded commands with process algebraic composition, with two minor extensions.
We apply the approach to a prominent example of cross-talk between the three pathways: TGF-β , WNT and MAPK. We
both detect and categorise 9 cross-talks.
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Several future directions have been identified. As suggested earlier, longer term, we will apply our approach to models
with a higher level of quantitative detail: to make better predictions and gain further insights into the biological effects of
cross-talk. We will also consider the relationship between cross-talks and standard pathway motifs. For example, is there a
reasonable alteration of a pathwaymodel (e.g. addition of a feedback loop) that gives the samebehaviour as a potential cross-
talk?Wewill also assess how the effectiveness of pathway intervention techniques such as drugs and gene knockouts change
with the addition of cross-talk. Finally, a larger question is how the temporal ordering of signals affects the detectability and
behaviour of cross-talk; for example, do pathways hold a ‘‘biochemical history’’ of signalling events?
The cross-talk generation program (incl. source code), PRISMmodels and logic properties used in this paper can be found
at www.dcs.gla.ac.uk/∼radonald/tcs2012/.
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Appendix. Cross-talk generation
We describe below a method to generate every cross-talk between two pathways P1 and P2. First, we consider substrate
availability cross-talk and then, all other types of cross-talk.
To generate every substrate availability cross-talk we share between pathways every pair of (external) variables.
for variable v ∈ extv(P1) do
for variablew ∈ extv(P2) do
P1 {renamings1} |[E ∪ U, V ]| Pathway2 {renamings2} where U = aux(P1) ∪ aux(P2), E = ∅, renamings1 = ∅,
renamings2 = ∅ and V = {(v,w)}
end for
end for
To generate every cross-talk of all other types we create all possible candidate cross-talks by synchronising up to k
(external) reactions.
for i ≥ 1, j ≥ 1 such that i+ j ≤ k do
for X = choose i reactions from extr(P1) do
for Y = choose j reactions from extr(P2) do
if X ∪ Y contains only modifiers then skip else
P1 {renamings1} |[E ∪ U, V ]| P2 {renamings2}where
renamings1 such that ∀x ∈ X .x ← rnew , renamings2
such that ∀y ∈ Y .y ← rnew , E = {rnew} and
U = (aux(P1 {renamings1}) ∪ aux(P2 {renamings2})) \ mapped(rnew),
end for
end for
end for
We then filter the candidate cross-talks according to the categorisation — those cross-talks that are not categorised are
removed.
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